SCHEMBL3772956

SCHEMBL3772956

CON=Cc1ccc(-c2ccccc2NC(=O)C2=C(C(F)(F)F)OCCS2)cc1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
KMT2A Q03164 3/20 0.36
NPC1 O15118 1/20 0.36
POLB P06746 1/20 0.36
ALDH1A1 P00352 4/20 0.36
NTRK1 P04629 1/20 0.36
ABCG2 Q9UNQ0 1/20 0.35
KDM4E B2RXH2 3/20 0.34
MAPT P10636 2/20 0.34
HTT P42858 2/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
CHRM3 P20309 1/20 0.34
TACR1 P25103 1/20 0.34
MEN1 O00255 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13001939 1.00 MAPK1 (0.38) MAPK1HSD17B10KMT2ANPC1POLB
SCHEMBL13001957 0.91 MAPK1 (0.37) MAPK1HSD17B10KMT2ANPC1POLB
SCHEMBL13001958 0.90 POLB (0.38) MAPK1HSD17B10KMT2ANPC1POLB
SCHEMBL14578353 0.87 MAPK1 (0.53) MAPK1HSD17B10KMT2ANPC1POLB
SCHEMBL13001955 0.84 NTRK1 (0.47) MAPK1HSD17B10KMT2ANPC1ALDH1A1
SCHEMBL3772954 0.84 ABCG2 (0.40) MAPK1HSD17B10KMT2ANPC1POLB
SCHEMBL13002016 0.83 ALDH1A1 (0.40) MAPK1HSD17B10KMT2ANPC1POLB
SCHEMBL13001998 0.82 KMT2A (0.39) MAPK1HSD17B10KMT2ANPC1POLB
SCHEMBL14380469 0.80 ALDH1A1 (0.38) MAPK1HSD17B10KMT2ANPC1POLB
SCHEMBL13001982 0.79 MAPK1 (0.43) MAPK1HSD17B10KMT2ANPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7847108-B2 such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms BAYER CROPSCIENCE AG (DE) 2010-12-07 US disclosed
US-20070004793-A1 such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms BAYER INTELLECTUAL PROPERTY GMBH (DE) 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004793-A1 such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms Q6ZSR9, PFAS, NIT2 MAPK1 3590/4885HSD17B10 3877/4885KMT2A 1138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.